2017 update of the drug resistance mutations in HIV-1

Annemarie M. Wensing; Vincent Calvez; Huldrych F. Günthard; Victoria A. Johnson; Roger Paredes; Deenan Pillay; Robert W. Shafer; Douglas D. Richman

2017 update of the drug resistance mutations in HIV-1

Annemarie M. Wensing, Vincent Calvez, Huldrych F. Günthard, Victoria A. Johnson, Roger Paredes, Deenan Pillay, Robert W. Shafer, Douglas D. Richman

Research output: Contribution to journal › Article › Academic › peer-review

22 Citations (Scopus)

Abstract

The 2017 edition of the IAS–USA drug resistance mutations list updates the figures last published in November 2015. The mutations listed are those that have been identified by specific criteria for evidence and drugs described. The figures are designed to assist practitioners in identifying key mutations associated with resistance to antiretroviral drugs and, therefore, in making clinical decisions regarding antiretroviral therapy.

Original language	English
Pages (from-to)	132-141
Number of pages	10
Journal	Topics in Antiviral Medicine
Volume	24
Issue number	4
Publication status	Published - Dec 2016

Keywords

HIV/AIDS
Basic Science
Special Contribution

Access to Document

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5677049/

Cite this

@article{924090cdaa444a36a24be82473fed6c3,

title = "2017 update of the drug resistance mutations in HIV-1",

abstract = "The 2017 edition of the IAS–USA drug resistance mutations list updates the figures last published in November 2015. The mutations listed are those that have been identified by specific criteria for evidence and drugs described. The figures are designed to assist practitioners in identifying key mutations associated with resistance to antiretroviral drugs and, therefore, in making clinical decisions regarding antiretroviral therapy.",

keywords = "HIV/AIDS, Basic Science, Special Contribution",

author = "Wensing, {Annemarie M.} and Vincent Calvez and G{\"u}nthard, {Huldrych F.} and Johnson, {Victoria A.} and Roger Paredes and Deenan Pillay and Shafer, {Robert W.} and Richman, {Douglas D.}",

year = "2016",

month = dec,

language = "English",

volume = "24",

pages = "132--141",

journal = "Topics in Antiviral Medicine",

issn = "2161-5861",

publisher = "International Antiviral Society",

number = "4",

}

TY - JOUR

T1 - 2017 update of the drug resistance mutations in HIV-1

AU - Wensing, Annemarie M.

AU - Calvez, Vincent

AU - Günthard, Huldrych F.

AU - Johnson, Victoria A.

AU - Paredes, Roger

AU - Pillay, Deenan

AU - Shafer, Robert W.

AU - Richman, Douglas D.

PY - 2016/12

Y1 - 2016/12

N2 - The 2017 edition of the IAS–USA drug resistance mutations list updates the figures last published in November 2015. The mutations listed are those that have been identified by specific criteria for evidence and drugs described. The figures are designed to assist practitioners in identifying key mutations associated with resistance to antiretroviral drugs and, therefore, in making clinical decisions regarding antiretroviral therapy.

AB - The 2017 edition of the IAS–USA drug resistance mutations list updates the figures last published in November 2015. The mutations listed are those that have been identified by specific criteria for evidence and drugs described. The figures are designed to assist practitioners in identifying key mutations associated with resistance to antiretroviral drugs and, therefore, in making clinical decisions regarding antiretroviral therapy.

KW - HIV/AIDS

KW - Basic Science

KW - Special Contribution

UR - http://www.scopus.com/inward/record.url?scp=85018193894&partnerID=8YFLogxK

M3 - Article

C2 - 28208121

AN - SCOPUS:85017704889

SN - 2161-5861

VL - 24

SP - 132

EP - 141

JO - Topics in Antiviral Medicine

JF - Topics in Antiviral Medicine

IS - 4

ER -

2017 update of the drug resistance mutations in HIV-1

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this